ORBi: Hiligsmann Mickaël - Cost-effectiveness of Bazedoxifene compared with Raloxifene in the treatment of postmenopausal osteoporotic women

Reference : Cost-effectiveness of Bazedoxifene compared with Raloxifene in the treatment of postmeno...


	Document type :	Scientific congresses and symposiums : Paper published in a journal
	Discipline(s) :	Human health sciences : General & internal medicine
	To cite this reference:	http://hdl.handle.net/2268/134706

Title :	Cost-effectiveness of Bazedoxifene compared with Raloxifene in the treatment of postmenopausal osteoporotic women
Language :	English
Author, co-author :	Hiligsmann, Mickaël [Université de Liège - ULg > Département des sciences de la santé publique > Département des sciences de la santé publique >]
	Ben Sedrine, Wafa [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
	Reginster, Jean-Yves [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Publication date :	2012
Journal title :	Arthritis and Rheumatism
Publisher :	Wiley Liss, Inc.
Volume :	64
Issue/season :	S10
Pages :	S834
Audience :	International
ISSN :	0004-3591
e-ISSN :	1529-0131
City :	New York
Country :	NY
Event name :	ACR/ARHP Annual Meeting
Event date :	Du 9 novembre 2012 au 14 novembre 2012
Event place (city) :	Washington D.C.
Event country :	U.S.A.
Permalink :	http://hdl.handle.net/2268/134706

File(s) associated to this reference

Fulltext file(s):

	File	Commentary	Version	Size	Access
Restricted access	Cost-effectiveness of bazedoxifene compared with raloxifene in the treatment of postmenopausal osteoporotic women.pdf		Publisher postprint	216.21 kB	Request copy

All documents in ORBi are protected by a user license.